Skip to main content
search

News

Sign up

Category Heading

Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan
Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in JapanAnnouncement

Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan

Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics Capabilities
Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics CapabilitiesAnnouncement

Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics Capabilities

Certara Awarded European Medicines Agency Project to Assess Real-World Data Landscape for CAR-T Cell Therapies
Certara Awarded European Medicines Agency Project to Assess Real-World Data Landscape for CAR-T Cell TherapiesAnnouncement

Certara Awarded European Medicines Agency Project to Assess Real-World Data Landscape for CAR-T Cell Therapies

Certara Appoints New Head of Biometrics, Data Science, and Access
Certara Appoints New Head of Biometrics, Data Science, and AccessAnnouncement

Certara Appoints New Head of Biometrics, Data Science, and Access

Certara Launches Updated Version of SEND Explorer® Software
Certara Launches Updated Version of SEND Explorer® SoftwareAnnouncement

Certara Launches Updated Version of SEND Explorer® Software

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process
Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission ProcessAnnouncement

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

All resources heading

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.